All Drugs Associated with Bone pain (Page 2)
859 drugs have been associated with Bone pain in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| EMTRICITABINE\TENOFOVIR DISOPROXIL | 240 | 1 | 39 | 1 |
| PERTUZUMAB | 240 | 4 | 124 | 4 |
| ASFOTASE ALFA | 239 | 0 | 11 | 1 |
| ATORVASTATIN | 233 | 13 | 48 | 8 |
| PREGABALIN | 232 | 1 | 63 | 4 |
| ADEFOVIR DIPIVOXIL | 213 | 3 | 129 | 1 |
| PEMBROLIZUMAB | 206 | 13 | 68 | 12 |
| TAMOXIFEN | 204 | 3 | 22 | 8 |
| RELUGOLIX | 199 | 0 | 25 | 0 |
| RIBAVIRIN | 194 | 0 | 19 | 5 |
| PONATINIB | 193 | 28 | 103 | 1 |
| NIVOLUMAB | 192 | 26 | 77 | 10 |
| ROMOSOZUMAB-AQQG | 189 | 1 | 16 | 3 |
| TOCILIZUMAB | 187 | 3 | 39 | 19 |
| OMEPRAZOLE | 184 | 3 | 51 | 1 |
| SELEXIPAG | 181 | 9 | 88 | 4 |
| INFLIXIMAB | 176 | 1 | 52 | 3 |
| MORPHINE | 176 | 8 | 101 | 10 |
| PARATHYROID HORMONE | 176 | 0 | 22 | 3 |
| PEGINTERFERON ALFA-2A | 174 | 0 | 16 | 3 |
| HUMAN IMMUNOGLOBULIN G | 172 | 4 | 37 | 1 |
| TENOFOVIR DISOPROXIL | 171 | 4 | 36 | 2 |
| GABAPENTIN | 170 | 1 | 60 | 1 |
| METFORMIN | 169 | 7 | 66 | 11 |
| PANTOPRAZOLE | 169 | 0 | 80 | 6 |
| APREMILAST | 167 | 0 | 9 | 0 |
| BUROSUMAB-TWZA | 162 | 0 | 2 | 0 |
| AMBRISENTAN | 158 | 1 | 46 | 2 |
| ELACESTRANT | 158 | 4 | 22 | 0 |
| ABIRATERONE | 157 | 21 | 45 | 2 |
| AVAPRITINIB | 156 | 0 | 10 | 0 |
| VENETOCLAX | 153 | 30 | 58 | 5 |
| ROSUVASTATIN | 152 | 1 | 13 | 4 |
| ABATACEPT | 151 | 1 | 42 | 2 |
| CABOZANTINIB S-MALATE | 151 | 5 | 25 | 1 |
| OXYCODONE | 150 | 7 | 50 | 4 |
| ETOPOSIDE | 149 | 14 | 87 | 46 |
| MACITENTAN | 147 | 20 | 86 | 5 |
| ECULIZUMAB | 146 | 4 | 29 | 3 |
| RADIUM RA-223 DICHLORIDE | 146 | 30 | 49 | 0 |
| EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL | 145 | 2 | 13 | 0 |
| ACETAMINOPHEN | 144 | 18 | 82 | 35 |
| AMLODIPINE | 144 | 2 | 38 | 21 |
| LENVATINIB | 140 | 4 | 76 | 2 |
| OCRELIZUMAB | 140 | 1 | 30 | 1 |
| SOMATROPIN | 139 | 0 | 13 | 1 |
| PREDNISOLONE | 138 | 4 | 69 | 41 |
| DICLOFENAC | 135 | 4 | 69 | 39 |
| DARATUMUMAB | 134 | 15 | 56 | 15 |
| PROLIA | 130 | 0 | 8 | 0 |